Merck carbapenem continues to yield positive results in preclinical and clinical studies June 2, 2000
In vitro and clinical data for daptomycin presented at ECCMID; Cubist accelerates development June 2, 2000
FDA approves Relenza for treatment of pediatric influenza; E.U. prophylaxis filing updated May 31, 2000
RSS